カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界のフラタキシンミトコンドリア市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Frataxin Mitochondrial Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO19335）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO19335
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：114
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界のフラタキシンミトコンドリア市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

フラタキシンミトコンドリア市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界のフラタキシンミトコンドリアの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

フラタキシンミトコンドリア市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・フリードライヒ運動失調症タンパク質、FXN、EC 1.16.3.1

用途別セグメントは次のように区分されます。
・中枢神経系、心血管系

世界のフラタキシンミトコンドリア市場の主要な市場プレーヤーは以下のとおりです。
・AavantiBio Inc、Adverum Biotechnologies Inc、Anima Biotech Inc、Biointaxis SL、Cellivery Therapeutics Inc、CRISPR Therapeutics AG、Design Therapeutics Inc、Fratagene Therapeutics Srl、Fulcrum Therapeutics Inc、Jupiter Orphan Therapeutics Inc、Lacerta Therapeutics Inc、Larimar Therapeutics Inc、Novartis Gene Therapies、PTC Therapeutics Inc、Voyager Therapeutics Inc

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、フラタキシンミトコンドリア製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なフラタキシンミトコンドリアメーカーの企業概要、2019年～2022年までのフラタキシンミトコンドリアの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なフラタキシンミトコンドリアメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別フラタキシンミトコンドリアの販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までのフラタキシンミトコンドリアの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのフラタキシンミトコンドリア市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、およびフラタキシンミトコンドリアの産業チェーンを掲載しています。
・第13、14、15章では、フラタキシンミトコンドリアの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- フラタキシンミトコンドリアの概要
- 種類別分析（2017年vs2021年vs2028年）：フリードライヒ運動失調症タンパク質、FXN、EC 1.16.3.1
- 用途別分析（2017年vs2021年vs2028年）：中枢神経系、心血管系
- 世界のフラタキシンミトコンドリア市場規模・予測
- 世界のフラタキシンミトコンドリア生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- AavantiBio Inc、Adverum Biotechnologies Inc、Anima Biotech Inc、Biointaxis SL、Cellivery Therapeutics Inc、CRISPR Therapeutics AG、Design Therapeutics Inc、Fratagene Therapeutics Srl、Fulcrum Therapeutics Inc、Jupiter Orphan Therapeutics Inc、Lacerta Therapeutics Inc、Larimar Therapeutics Inc、Novartis Gene Therapies、PTC Therapeutics Inc、Voyager Therapeutics Inc
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：フリードライヒ運動失調症タンパク質、FXN、EC 1.16.3.1
・用途別分析2017年-2028年：中枢神経系、心血管系
・フラタキシンミトコンドリアの北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・フラタキシンミトコンドリアのヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・フラタキシンミトコンドリアのアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・フラタキシンミトコンドリアの南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・フラタキシンミトコンドリアの中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Frataxin Mitochondrial market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Frataxin Mitochondrial market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Central Nervous System accounting for % of the Frataxin Mitochondrial global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Friedreich Ataxia Protein segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Frataxin Mitochondrial include AavantiBio Inc, Adverum Biotechnologies Inc, Anima Biotech Inc, Biointaxis SL, and Cellivery Therapeutics Inc, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Frataxin Mitochondrial market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Friedreich Ataxia Protein
FXN
EC 1.16.3.1
Market segment by Application can be divided into
Central Nervous System
Cardiovascular
The key market players for global Frataxin Mitochondrial market are listed below:
AavantiBio Inc
Adverum Biotechnologies Inc
Anima Biotech Inc
Biointaxis SL
Cellivery Therapeutics Inc
CRISPR Therapeutics AG
Design Therapeutics Inc
Fratagene Therapeutics Srl
Fulcrum Therapeutics Inc
Jupiter Orphan Therapeutics Inc
Lacerta Therapeutics Inc
Larimar Therapeutics Inc
Novartis Gene Therapies
PTC Therapeutics Inc
Voyager Therapeutics Inc
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Frataxin Mitochondrial product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Frataxin Mitochondrial, with price, sales, revenue and global market share of Frataxin Mitochondrial from 2019 to 2022.
Chapter 3, the Frataxin Mitochondrial competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Frataxin Mitochondrial breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Frataxin Mitochondrial market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Frataxin Mitochondrial.
Chapter 13, 14, and 15, to describe Frataxin Mitochondrial sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Frataxin Mitochondrial Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Frataxin Mitochondrial Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Friedreich Ataxia Protein
1.2.3 FXN
1.2.4 EC 1.16.3.1
1.3 Market Analysis by Application
1.3.1 Overview: Global Frataxin Mitochondrial Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Central Nervous System
1.3.3 Cardiovascular
1.4 Global Frataxin Mitochondrial Market Size & Forecast
1.4.1 Global Frataxin Mitochondrial Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Frataxin Mitochondrial Sales in Volume (2017-2028)
1.4.3 Global Frataxin Mitochondrial Price (2017-2028)
1.5 Global Frataxin Mitochondrial Production Capacity Analysis
1.5.1 Global Frataxin Mitochondrial Total Production Capacity (2017-2028)
1.5.2 Global Frataxin Mitochondrial Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Frataxin Mitochondrial Market Drivers
1.6.2 Frataxin Mitochondrial Market Restraints
1.6.3 Frataxin Mitochondrial Trends Analysis
2 Manufacturers Profiles
2.1 AavantiBio Inc
2.1.1 AavantiBio Inc Details
2.1.2 AavantiBio Inc Major Business
2.1.3 AavantiBio Inc Frataxin Mitochondrial Product and Services
2.1.4 AavantiBio Inc Frataxin Mitochondrial Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Adverum Biotechnologies Inc
2.2.1 Adverum Biotechnologies Inc Details
2.2.2 Adverum Biotechnologies Inc Major Business
2.2.3 Adverum Biotechnologies Inc Frataxin Mitochondrial Product and Services
2.2.4 Adverum Biotechnologies Inc Frataxin Mitochondrial Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Anima Biotech Inc
2.3.1 Anima Biotech Inc Details
2.3.2 Anima Biotech Inc Major Business
2.3.3 Anima Biotech Inc Frataxin Mitochondrial Product and Services
2.3.4 Anima Biotech Inc Frataxin Mitochondrial Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Biointaxis SL
2.4.1 Biointaxis SL Details
2.4.2 Biointaxis SL Major Business
2.4.3 Biointaxis SL Frataxin Mitochondrial Product and Services
2.4.4 Biointaxis SL Frataxin Mitochondrial Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Cellivery Therapeutics Inc
2.5.1 Cellivery Therapeutics Inc Details
2.5.2 Cellivery Therapeutics Inc Major Business
2.5.3 Cellivery Therapeutics Inc Frataxin Mitochondrial Product and Services
2.5.4 Cellivery Therapeutics Inc Frataxin Mitochondrial Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 CRISPR Therapeutics AG
2.6.1 CRISPR Therapeutics AG Details
2.6.2 CRISPR Therapeutics AG Major Business
2.6.3 CRISPR Therapeutics AG Frataxin Mitochondrial Product and Services
2.6.4 CRISPR Therapeutics AG Frataxin Mitochondrial Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Design Therapeutics Inc
2.7.1 Design Therapeutics Inc Details
2.7.2 Design Therapeutics Inc Major Business
2.7.3 Design Therapeutics Inc Frataxin Mitochondrial Product and Services
2.7.4 Design Therapeutics Inc Frataxin Mitochondrial Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Fratagene Therapeutics Srl
2.8.1 Fratagene Therapeutics Srl Details
2.8.2 Fratagene Therapeutics Srl Major Business
2.8.3 Fratagene Therapeutics Srl Frataxin Mitochondrial Product and Services
2.8.4 Fratagene Therapeutics Srl Frataxin Mitochondrial Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Fulcrum Therapeutics Inc
2.9.1 Fulcrum Therapeutics Inc Details
2.9.2 Fulcrum Therapeutics Inc Major Business
2.9.3 Fulcrum Therapeutics Inc Frataxin Mitochondrial Product and Services
2.9.4 Fulcrum Therapeutics Inc Frataxin Mitochondrial Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Jupiter Orphan Therapeutics Inc
2.10.1 Jupiter Orphan Therapeutics Inc Details
2.10.2 Jupiter Orphan Therapeutics Inc Major Business
2.10.3 Jupiter Orphan Therapeutics Inc Frataxin Mitochondrial Product and Services
2.10.4 Jupiter Orphan Therapeutics Inc Frataxin Mitochondrial Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Lacerta Therapeutics Inc
2.11.1 Lacerta Therapeutics Inc Details
2.11.2 Lacerta Therapeutics Inc Major Business
2.11.3 Lacerta Therapeutics Inc Frataxin Mitochondrial Product and Services
2.11.4 Lacerta Therapeutics Inc Frataxin Mitochondrial Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Larimar Therapeutics Inc
2.12.1 Larimar Therapeutics Inc Details
2.12.2 Larimar Therapeutics Inc Major Business
2.12.3 Larimar Therapeutics Inc Frataxin Mitochondrial Product and Services
2.12.4 Larimar Therapeutics Inc Frataxin Mitochondrial Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Novartis Gene Therapies
2.13.1 Novartis Gene Therapies Details
2.13.2 Novartis Gene Therapies Major Business
2.13.3 Novartis Gene Therapies Frataxin Mitochondrial Product and Services
2.13.4 Novartis Gene Therapies Frataxin Mitochondrial Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 PTC Therapeutics Inc
2.14.1 PTC Therapeutics Inc Details
2.14.2 PTC Therapeutics Inc Major Business
2.14.3 PTC Therapeutics Inc Frataxin Mitochondrial Product and Services
2.14.4 PTC Therapeutics Inc Frataxin Mitochondrial Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15 Voyager Therapeutics Inc
2.15.1 Voyager Therapeutics Inc Details
2.15.2 Voyager Therapeutics Inc Major Business
2.15.3 Voyager Therapeutics Inc Frataxin Mitochondrial Product and Services
2.15.4 Voyager Therapeutics Inc Frataxin Mitochondrial Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Frataxin Mitochondrial Breakdown Data by Manufacturer
3.1 Global Frataxin Mitochondrial Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Frataxin Mitochondrial Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Frataxin Mitochondrial
3.4 Market Concentration Rate
3.4.1 Top 3 Frataxin Mitochondrial Manufacturer Market Share in 2021
3.4.2 Top 6 Frataxin Mitochondrial Manufacturer Market Share in 2021
3.5 Global Frataxin Mitochondrial Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Frataxin Mitochondrial Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Frataxin Mitochondrial Market Size by Region
4.1.1 Global Frataxin Mitochondrial Sales in Volume by Region (2017-2028)
4.1.2 Global Frataxin Mitochondrial Revenue by Region (2017-2028)
4.2 North America Frataxin Mitochondrial Revenue (2017-2028)
4.3 Europe Frataxin Mitochondrial Revenue (2017-2028)
4.4 Asia-Pacific Frataxin Mitochondrial Revenue (2017-2028)
4.5 South America Frataxin Mitochondrial Revenue (2017-2028)
4.6 Middle East and Africa Frataxin Mitochondrial Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Frataxin Mitochondrial Sales in Volume by Type (2017-2028)
5.2 Global Frataxin Mitochondrial Revenue by Type (2017-2028)
5.3 Global Frataxin Mitochondrial Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Frataxin Mitochondrial Sales in Volume by Application (2017-2028)
6.2 Global Frataxin Mitochondrial Revenue by Application (2017-2028)
6.3 Global Frataxin Mitochondrial Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Frataxin Mitochondrial Sales by Type (2017-2028)
7.2 North America Frataxin Mitochondrial Sales by Application (2017-2028)
7.3 North America Frataxin Mitochondrial Market Size by Country
7.3.1 North America Frataxin Mitochondrial Sales in Volume by Country (2017-2028)
7.3.2 North America Frataxin Mitochondrial Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Frataxin Mitochondrial Sales by Type (2017-2028)
8.2 Europe Frataxin Mitochondrial Sales by Application (2017-2028)
8.3 Europe Frataxin Mitochondrial Market Size by Country
8.3.1 Europe Frataxin Mitochondrial Sales in Volume by Country (2017-2028)
8.3.2 Europe Frataxin Mitochondrial Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Frataxin Mitochondrial Sales by Type (2017-2028)
9.2 Asia-Pacific Frataxin Mitochondrial Sales by Application (2017-2028)
9.3 Asia-Pacific Frataxin Mitochondrial Market Size by Region
9.3.1 Asia-Pacific Frataxin Mitochondrial Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Frataxin Mitochondrial Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Frataxin Mitochondrial Sales by Type (2017-2028)
10.2 South America Frataxin Mitochondrial Sales by Application (2017-2028)
10.3 South America Frataxin Mitochondrial Market Size by Country
10.3.1 South America Frataxin Mitochondrial Sales in Volume by Country (2017-2028)
10.3.2 South America Frataxin Mitochondrial Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Frataxin Mitochondrial Sales by Type (2017-2028)
11.2 Middle East & Africa Frataxin Mitochondrial Sales by Application (2017-2028)
11.3 Middle East & Africa Frataxin Mitochondrial Market Size by Country
11.3.1 Middle East & Africa Frataxin Mitochondrial Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Frataxin Mitochondrial Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Frataxin Mitochondrial and Key Manufacturers
12.2 Manufacturing Costs Percentage of Frataxin Mitochondrial
12.3 Frataxin Mitochondrial Production Process
12.4 Frataxin Mitochondrial Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Frataxin Mitochondrial Typical Distributors
13.3 Frataxin Mitochondrial Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Frataxin Mitochondrial Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Frataxin Mitochondrial Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. AavantiBio Inc Basic Information, Manufacturing Base and Competitors
Table 4. AavantiBio Inc Major Business
Table 5. AavantiBio Inc Frataxin Mitochondrial Product and Services
Table 6. AavantiBio Inc Frataxin Mitochondrial Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Adverum Biotechnologies Inc Basic Information, Manufacturing Base and Competitors
Table 8. Adverum Biotechnologies Inc Major Business
Table 9. Adverum Biotechnologies Inc Frataxin Mitochondrial Product and Services
Table 10. Adverum Biotechnologies Inc Frataxin Mitochondrial Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Anima Biotech Inc Basic Information, Manufacturing Base and Competitors
Table 12. Anima Biotech Inc Major Business
Table 13. Anima Biotech Inc Frataxin Mitochondrial Product and Services
Table 14. Anima Biotech Inc Frataxin Mitochondrial Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Biointaxis SL Basic Information, Manufacturing Base and Competitors
Table 16. Biointaxis SL Major Business
Table 17. Biointaxis SL Frataxin Mitochondrial Product and Services
Table 18. Biointaxis SL Frataxin Mitochondrial Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Cellivery Therapeutics Inc Basic Information, Manufacturing Base and Competitors
Table 20. Cellivery Therapeutics Inc Major Business
Table 21. Cellivery Therapeutics Inc Frataxin Mitochondrial Product and Services
Table 22. Cellivery Therapeutics Inc Frataxin Mitochondrial Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. CRISPR Therapeutics AG Basic Information, Manufacturing Base and Competitors
Table 24. CRISPR Therapeutics AG Major Business
Table 25. CRISPR Therapeutics AG Frataxin Mitochondrial Product and Services
Table 26. CRISPR Therapeutics AG Frataxin Mitochondrial Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Design Therapeutics Inc Basic Information, Manufacturing Base and Competitors
Table 28. Design Therapeutics Inc Major Business
Table 29. Design Therapeutics Inc Frataxin Mitochondrial Product and Services
Table 30. Design Therapeutics Inc Frataxin Mitochondrial Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Fratagene Therapeutics Srl Basic Information, Manufacturing Base and Competitors
Table 32. Fratagene Therapeutics Srl Major Business
Table 33. Fratagene Therapeutics Srl Frataxin Mitochondrial Product and Services
Table 34. Fratagene Therapeutics Srl Frataxin Mitochondrial Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Fulcrum Therapeutics Inc Basic Information, Manufacturing Base and Competitors
Table 36. Fulcrum Therapeutics Inc Major Business
Table 37. Fulcrum Therapeutics Inc Frataxin Mitochondrial Product and Services
Table 38. Fulcrum Therapeutics Inc Frataxin Mitochondrial Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Jupiter Orphan Therapeutics Inc Basic Information, Manufacturing Base and Competitors
Table 40. Jupiter Orphan Therapeutics Inc Major Business
Table 41. Jupiter Orphan Therapeutics Inc Frataxin Mitochondrial Product and Services
Table 42. Jupiter Orphan Therapeutics Inc Frataxin Mitochondrial Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Lacerta Therapeutics Inc Basic Information, Manufacturing Base and Competitors
Table 44. Lacerta Therapeutics Inc Major Business
Table 45. Lacerta Therapeutics Inc Frataxin Mitochondrial Product and Services
Table 46. Lacerta Therapeutics Inc Frataxin Mitochondrial Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Larimar Therapeutics Inc Basic Information, Manufacturing Base and Competitors
Table 48. Larimar Therapeutics Inc Major Business
Table 49. Larimar Therapeutics Inc Frataxin Mitochondrial Product and Services
Table 50. Larimar Therapeutics Inc Frataxin Mitochondrial Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. Novartis Gene Therapies Basic Information, Manufacturing Base and Competitors
Table 52. Novartis Gene Therapies Major Business
Table 53. Novartis Gene Therapies Frataxin Mitochondrial Product and Services
Table 54. Novartis Gene Therapies Frataxin Mitochondrial Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 55. PTC Therapeutics Inc Basic Information, Manufacturing Base and Competitors
Table 56. PTC Therapeutics Inc Major Business
Table 57. PTC Therapeutics Inc Frataxin Mitochondrial Product and Services
Table 58. PTC Therapeutics Inc Frataxin Mitochondrial Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 59. Voyager Therapeutics Inc Basic Information, Manufacturing Base and Competitors
Table 60. Voyager Therapeutics Inc Major Business
Table 61. Voyager Therapeutics Inc Frataxin Mitochondrial Product and Services
Table 62. Voyager Therapeutics Inc Frataxin Mitochondrial Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 63. Global Frataxin Mitochondrial Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 64. Global Frataxin Mitochondrial Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 65. Market Position of Manufacturers in Frataxin Mitochondrial, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 66. Global Frataxin Mitochondrial Production Capacity by Company, (K Units): 2020 VS 2021
Table 67. Head Office and Frataxin Mitochondrial Production Site of Key Manufacturer
Table 68. Frataxin Mitochondrial New Entrant and Capacity Expansion Plans
Table 69. Frataxin Mitochondrial Mergers & Acquisitions in the Past Five Years
Table 70. Global Frataxin Mitochondrial Sales by Region (2017-2022) & (K Units)
Table 71. Global Frataxin Mitochondrial Sales by Region (2023-2028) & (K Units)
Table 72. Global Frataxin Mitochondrial Revenue by Region (2017-2022) & (USD Million)
Table 73. Global Frataxin Mitochondrial Revenue by Region (2023-2028) & (USD Million)
Table 74. Global Frataxin Mitochondrial Sales by Type (2017-2022) & (K Units)
Table 75. Global Frataxin Mitochondrial Sales by Type (2023-2028) & (K Units)
Table 76. Global Frataxin Mitochondrial Revenue by Type (2017-2022) & (USD Million)
Table 77. Global Frataxin Mitochondrial Revenue by Type (2023-2028) & (USD Million)
Table 78. Global Frataxin Mitochondrial Price by Type (2017-2022) & (US$/Unit)
Table 79. Global Frataxin Mitochondrial Price by Type (2023-2028) & (US$/Unit)
Table 80. Global Frataxin Mitochondrial Sales by Application (2017-2022) & (K Units)
Table 81. Global Frataxin Mitochondrial Sales by Application (2023-2028) & (K Units)
Table 82. Global Frataxin Mitochondrial Revenue by Application (2017-2022) & (USD Million)
Table 83. Global Frataxin Mitochondrial Revenue by Application (2023-2028) & (USD Million)
Table 84. Global Frataxin Mitochondrial Price by Application (2017-2022) & (US$/Unit)
Table 85. Global Frataxin Mitochondrial Price by Application (2023-2028) & (US$/Unit)
Table 86. North America Frataxin Mitochondrial Sales by Country (2017-2022) & (K Units)
Table 87. North America Frataxin Mitochondrial Sales by Country (2023-2028) & (K Units)
Table 88. North America Frataxin Mitochondrial Revenue by Country (2017-2022) & (USD Million)
Table 89. North America Frataxin Mitochondrial Revenue by Country (2023-2028) & (USD Million)
Table 90. North America Frataxin Mitochondrial Sales by Type (2017-2022) & (K Units)
Table 91. North America Frataxin Mitochondrial Sales by Type (2023-2028) & (K Units)
Table 92. North America Frataxin Mitochondrial Sales by Application (2017-2022) & (K Units)
Table 93. North America Frataxin Mitochondrial Sales by Application (2023-2028) & (K Units)
Table 94. Europe Frataxin Mitochondrial Sales by Country (2017-2022) & (K Units)
Table 95. Europe Frataxin Mitochondrial Sales by Country (2023-2028) & (K Units)
Table 96. Europe Frataxin Mitochondrial Revenue by Country (2017-2022) & (USD Million)
Table 97. Europe Frataxin Mitochondrial Revenue by Country (2023-2028) & (USD Million)
Table 98. Europe Frataxin Mitochondrial Sales by Type (2017-2022) & (K Units)
Table 99. Europe Frataxin Mitochondrial Sales by Type (2023-2028) & (K Units)
Table 100. Europe Frataxin Mitochondrial Sales by Application (2017-2022) & (K Units)
Table 101. Europe Frataxin Mitochondrial Sales by Application (2023-2028) & (K Units)
Table 102. Asia-Pacific Frataxin Mitochondrial Sales by Region (2017-2022) & (K Units)
Table 103. Asia-Pacific Frataxin Mitochondrial Sales by Region (2023-2028) & (K Units)
Table 104. Asia-Pacific Frataxin Mitochondrial Revenue by Region (2017-2022) & (USD Million)
Table 105. Asia-Pacific Frataxin Mitochondrial Revenue by Region (2023-2028) & (USD Million)
Table 106. Asia-Pacific Frataxin Mitochondrial Sales by Type (2017-2022) & (K Units)
Table 107. Asia-Pacific Frataxin Mitochondrial Sales by Type (2023-2028) & (K Units)
Table 108. Asia-Pacific Frataxin Mitochondrial Sales by Application (2017-2022) & (K Units)
Table 109. Asia-Pacific Frataxin Mitochondrial Sales by Application (2023-2028) & (K Units)
Table 110. South America Frataxin Mitochondrial Sales by Country (2017-2022) & (K Units)
Table 111. South America Frataxin Mitochondrial Sales by Country (2023-2028) & (K Units)
Table 112. South America Frataxin Mitochondrial Revenue by Country (2017-2022) & (USD Million)
Table 113. South America Frataxin Mitochondrial Revenue by Country (2023-2028) & (USD Million)
Table 114. South America Frataxin Mitochondrial Sales by Type (2017-2022) & (K Units)
Table 115. South America Frataxin Mitochondrial Sales by Type (2023-2028) & (K Units)
Table 116. South America Frataxin Mitochondrial Sales by Application (2017-2022) & (K Units)
Table 117. South America Frataxin Mitochondrial Sales by Application (2023-2028) & (K Units)
Table 118. Middle East & Africa Frataxin Mitochondrial Sales by Region (2017-2022) & (K Units)
Table 119. Middle East & Africa Frataxin Mitochondrial Sales by Region (2023-2028) & (K Units)
Table 120. Middle East & Africa Frataxin Mitochondrial Revenue by Region (2017-2022) & (USD Million)
Table 121. Middle East & Africa Frataxin Mitochondrial Revenue by Region (2023-2028) & (USD Million)
Table 122. Middle East & Africa Frataxin Mitochondrial Sales by Type (2017-2022) & (K Units)
Table 123. Middle East & Africa Frataxin Mitochondrial Sales by Type (2023-2028) & (K Units)
Table 124. Middle East & Africa Frataxin Mitochondrial Sales by Application (2017-2022) & (K Units)
Table 125. Middle East & Africa Frataxin Mitochondrial Sales by Application (2023-2028) & (K Units)
Table 126. Frataxin Mitochondrial Raw Material
Table 127. Key Manufacturers of Frataxin Mitochondrial Raw Materials
Table 128. Direct Channel Pros & Cons
Table 129. Indirect Channel Pros & Cons
Table 130. Frataxin Mitochondrial Typical Distributors
Table 131. Frataxin Mitochondrial Typical Customers
List of Figures
Figure 1. Frataxin Mitochondrial Picture
Figure 2. Global Frataxin Mitochondrial Revenue Market Share by Type in 2021
Figure 3. Friedreich Ataxia Protein
Figure 4. FXN
Figure 5. EC 1.16.3.1
Figure 6. Global Frataxin Mitochondrial Revenue Market Share by Application in 2021
Figure 7. Central Nervous System
Figure 8. Cardiovascular
Figure 9. Global Frataxin Mitochondrial Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 10. Global Frataxin Mitochondrial Revenue and Forecast (2017-2028) & (USD Million)
Figure 11. Global Frataxin Mitochondrial Sales (2017-2028) & (K Units)
Figure 12. Global Frataxin Mitochondrial Price (2017-2028) & (US$/Unit)
Figure 13. Global Frataxin Mitochondrial Production Capacity (2017-2028) & (K Units)
Figure 14. Global Frataxin Mitochondrial Production Capacity by Geographic Region: 2022 VS 2028
Figure 15. Frataxin Mitochondrial Market Drivers
Figure 16. Frataxin Mitochondrial Market Restraints
Figure 17. Frataxin Mitochondrial Market Trends
Figure 18. Global Frataxin Mitochondrial Sales Market Share by Manufacturer in 2021
Figure 19. Global Frataxin Mitochondrial Revenue Market Share by Manufacturer in 2021
Figure 20. Frataxin Mitochondrial Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 21. Top 3 Frataxin Mitochondrial Manufacturer (Revenue) Market Share in 2021
Figure 22. Top 6 Frataxin Mitochondrial Manufacturer (Revenue) Market Share in 2021
Figure 23. Global Frataxin Mitochondrial Sales Market Share by Region (2017-2028)
Figure 24. Global Frataxin Mitochondrial Revenue Market Share by Region (2017-2028)
Figure 25. North America Frataxin Mitochondrial Revenue (2017-2028) & (USD Million)
Figure 26. Europe Frataxin Mitochondrial Revenue (2017-2028) & (USD Million)
Figure 27. Asia-Pacific Frataxin Mitochondrial Revenue (2017-2028) & (USD Million)
Figure 28. South America Frataxin Mitochondrial Revenue (2017-2028) & (USD Million)
Figure 29. Middle East & Africa Frataxin Mitochondrial Revenue (2017-2028) & (USD Million)
Figure 30. Global Frataxin Mitochondrial Sales Market Share by Type (2017-2028)
Figure 31. Global Frataxin Mitochondrial Revenue Market Share by Type (2017-2028)
Figure 32. Global Frataxin Mitochondrial Price by Type (2017-2028) & (US$/Unit)
Figure 33. Global Frataxin Mitochondrial Sales Market Share by Application (2017-2028)
Figure 34. Global Frataxin Mitochondrial Revenue Market Share by Application (2017-2028)
Figure 35. Global Frataxin Mitochondrial Price by Application (2017-2028) & (US$/Unit)
Figure 36. North America Frataxin Mitochondrial Sales Market Share by Type (2017-2028)
Figure 37. North America Frataxin Mitochondrial Sales Market Share by Application (2017-2028)
Figure 38. North America Frataxin Mitochondrial Sales Market Share by Country (2017-2028)
Figure 39. North America Frataxin Mitochondrial Revenue Market Share by Country (2017-2028)
Figure 40. United States Frataxin Mitochondrial Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Canada Frataxin Mitochondrial Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Mexico Frataxin Mitochondrial Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Europe Frataxin Mitochondrial Sales Market Share by Type (2017-2028)
Figure 44. Europe Frataxin Mitochondrial Sales Market Share by Application (2017-2028)
Figure 45. Europe Frataxin Mitochondrial Sales Market Share by Country (2017-2028)
Figure 46. Europe Frataxin Mitochondrial Revenue Market Share by Country (2017-2028)
Figure 47. Germany Frataxin Mitochondrial Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. France Frataxin Mitochondrial Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. United Kingdom Frataxin Mitochondrial Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Russia Frataxin Mitochondrial Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Italy Frataxin Mitochondrial Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Asia-Pacific Frataxin Mitochondrial Sales Market Share by Region (2017-2028)
Figure 53. Asia-Pacific Frataxin Mitochondrial Sales Market Share by Application (2017-2028)
Figure 54. Asia-Pacific Frataxin Mitochondrial Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Frataxin Mitochondrial Revenue Market Share by Region (2017-2028)
Figure 56. China Frataxin Mitochondrial Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Japan Frataxin Mitochondrial Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Korea Frataxin Mitochondrial Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. India Frataxin Mitochondrial Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Southeast Asia Frataxin Mitochondrial Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Australia Frataxin Mitochondrial Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. South America Frataxin Mitochondrial Sales Market Share by Type (2017-2028)
Figure 63. South America Frataxin Mitochondrial Sales Market Share by Application (2017-2028)
Figure 64. South America Frataxin Mitochondrial Sales Market Share by Country (2017-2028)
Figure 65. South America Frataxin Mitochondrial Revenue Market Share by Country (2017-2028)
Figure 66. Brazil Frataxin Mitochondrial Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Argentina Frataxin Mitochondrial Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Middle East & Africa Frataxin Mitochondrial Sales Market Share by Type (2017-2028)
Figure 69. Middle East & Africa Frataxin Mitochondrial Sales Market Share by Application (2017-2028)
Figure 70. Middle East & Africa Frataxin Mitochondrial Sales Market Share by Region (2017-2028)
Figure 71. Middle East & Africa Frataxin Mitochondrial Revenue Market Share by Region (2017-2028)
Figure 72. Turkey Frataxin Mitochondrial Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Egypt Frataxin Mitochondrial Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Saudi Arabia Frataxin Mitochondrial Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. South Africa Frataxin Mitochondrial Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Manufacturing Cost Structure Analysis of Frataxin Mitochondrial in 2021
Figure 77. Manufacturing Process Analysis of Frataxin Mitochondrial
Figure 78. Frataxin Mitochondrial Industrial Chain
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界のハンセン病治療市場2022年：市場規模予測（～2028年）
  • 世界のアンチセンス＆RNA干渉治療薬市場2022年：市場規模予測（～2028年）
  • 世界のガレクチン阻害治療薬市場2022年：市場規模予測（～2028年）
  • エピジェネティック治療のグローバル市場展望 2023年-2029年：PRAP（ホスホリボシルピロリン酸アミドトランスフェラーゼ）阻害剤、キナーゼ阻害剤、IDH（イソクエン酸脱水素酵素）阻害剤、HDAC（ヒストン脱アセチル化酵素）阻害剤、DNMT（DNAメチルトランスフェラーゼ）阻害剤
  • 世界の慢性閉塞性肺疾患治療薬市場2022年：市場規模予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO19335 )"世界のフラタキシンミトコンドリア市場2022年：市場規模予測（～2028年）" (英文：Global Frataxin Mitochondrial Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。